Skip to product information
1 of 1

Elabscience

SKU:E-AB-F1229J-200Tests

PerCP/Cyanine5.5 Anti-Human CD279/PD-1 Antibody[EH12.2H7]

PerCP/Cyanine5.5 Anti-Human CD279/PD-1 Antibody[EH12.2H7]

Regular price $330.00 USD
Regular price Sale price $330.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
The PERCP/CYANINE5.5 Anti-Human CD279/PD-1 Antibody [EH12.2H7] is a highly specific and reliable tool for the detection and analysis of human CD279/PD-1 protein expression. This antibody is conjugated with the PERCP/CYANINE5.5 fluorochrome, which provides excellent brightness and stability for flow cytometry applications.

CD279, also known as programmed cell death protein 1 (PD-1), is a cell surface receptor that plays a critical role in regulating immune responses. It is primarily expressed on activated T cells, B cells, and myeloid cells. The interaction between PD-1 and its ligands, PD-L1 and PD-L2, negatively regulates T cell activation and effector functions, thereby preventing excessive immune responses and maintaining immune homeostasis.

The PERCP/CYANINE5.5 Anti-Human CD279/PD-1 Antibody [EH12.2H7] has been extensively validated for its specificity and sensitivity in detecting CD279/PD-1 expression on various human cell types. It exhibits minimal cross-reactivity with other related proteins, ensuring accurate and reliable results. The PERCP/CYANINE5.5 fluorochrome provides a high signal-to-noise ratio, allowing for precise identification and quantification of CD279/PD-1-positive cells.

This antibody is supplied in a ready-to-use format, eliminating the need for additional conjugation steps. It is compatible with a wide range of flow cytometry instruments and can be used in both research and clinical settings. The PERCP/CYANINE5.5 Anti-Human CD279/PD-1 Antibody [EH12.2H7] offers excellent lot-to-lot consistency, ensuring reproducible results across experiments.

In summary, the PERCP/CYANINE5.5 Anti-Human CD279/PD-1 Antibody [EH12.2H7] is a highly specific and reliable tool for the detection and analysis of human CD279/PD-1 protein expression. Its exceptional performance characteristics make it an ideal choice for researchers and clinicians studying immune responses and developing therapeutic strategies targeting the PD-1 pathway.
View full details